Clinical Trials Browser

Phase 2 × Terminated × tucatinib × Clear all

NCT05583110 2025-12-10

TrasTUCAN

Phase 2 Terminated

Breast Neoplasms

NCT03501979 2025-08-29

Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD

Phase 2 Terminated

17 enrolled 16 charts

Breast Neoplasms, Meningeal Neoplasms